What is the primary purpose of growth factor support in high-risk chemotherapy regimens?

Prepare for the ONS ONCC Chemotherapy Exam. Enhance your skills with multiple choice questions and detailed explanations. Ensure you're ready for certification renewal!

Multiple Choice

What is the primary purpose of growth factor support in high-risk chemotherapy regimens?

Explanation:
Growth factor support is used to lessen the problem of neutropenia after intensive chemotherapy. By stimulating the bone marrow to produce neutrophils, these agents shorten how long neutropenia lasts and reduce the risk of neutropenic infections and febrile episodes. They are supportive, not cytotoxic, so they don’t kill tumor cells. They also don’t prevent anemia; that requires other treatments. They may help patients stay on their planned chemotherapy schedule, but the main goal is lowering infection risk through faster neutrophil recovery.

Growth factor support is used to lessen the problem of neutropenia after intensive chemotherapy. By stimulating the bone marrow to produce neutrophils, these agents shorten how long neutropenia lasts and reduce the risk of neutropenic infections and febrile episodes. They are supportive, not cytotoxic, so they don’t kill tumor cells. They also don’t prevent anemia; that requires other treatments. They may help patients stay on their planned chemotherapy schedule, but the main goal is lowering infection risk through faster neutrophil recovery.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy